Pitti Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 22, 2025, 9:26 am

Competitors of Pitti Engineering Ltd

All Competitor Stocks of Pitti Engineering Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:30 am

Below is a detailed analysis of the quarterly data for Pitti Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 382.00 Cr.. The value appears to be declining and may need further review. It has decreased from 422.00 Cr. (Mar 2025) to 382.00 Cr., marking a decrease of 40.00 Cr..
• For Expenses, as of Jun 2025, the value is 315.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 351.00 Cr. (Mar 2025) to 315.00 Cr., marking a decrease of 36.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 67.00 Cr.. The value appears to be declining and may need further review. It has decreased from 71.00 Cr. (Mar 2025) to 67.00 Cr., marking a decrease of 4.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 17.00% (Mar 2025) to 18.00%, marking an increase of 1.00%.
• For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 4.00 Cr..
• For Interest, as of Jun 2025, the value is 20.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 19.00 Cr. (Mar 2025) to 20.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 24.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 5.00 Cr..
• For Tax %, as of Jun 2025, the value is 40.00%. The value appears to be increasing, which may not be favorable. It has increased from 11.00% (Mar 2025) to 40.00%, marking an increase of 29.00%.
• For Net Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 30.00 Cr. (Mar 2025) to 18.00 Cr., marking a decrease of 12.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 4.67. The value appears to be declining and may need further review. It has decreased from 7.96 (Mar 2025) to 4.67, marking a decrease of 3.29.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:41 am

Growth

Last Updated: September 5, 2025, 12:20 pm

Balance Sheet

Last Updated: November 9, 2025, 2:42 pm

Below is a detailed analysis of the balance sheet data for Pitti Engineering Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 19.00 Cr..
• For Reserves, as of Sep 2025, the value is 897.00 Cr.. The value appears strong and on an upward trend. It has increased from 865.00 Cr. (Mar 2025) to 897.00 Cr., marking an increase of 32.00 Cr..
• For Borrowings, as of Sep 2025, the value is 776.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 687.00 Cr. (Mar 2025) to 776.00 Cr., marking an increase of 89.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 390.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 383.00 Cr. (Mar 2025) to 390.00 Cr., marking an increase of 7.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 2,081.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,954.00 Cr. (Mar 2025) to 2,081.00 Cr., marking an increase of 127.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 818.00 Cr.. The value appears strong and on an upward trend. It has increased from 793.00 Cr. (Mar 2025) to 818.00 Cr., marking an increase of 25.00 Cr..
• For CWIP, as of Sep 2025, the value is 63.00 Cr.. The value appears strong and on an upward trend. It has increased from 61.00 Cr. (Mar 2025) to 63.00 Cr., marking an increase of 2.00 Cr..
• For Investments, as of Sep 2025, the value is 258.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 258.00 Cr..
• For Other Assets, as of Sep 2025, the value is 941.00 Cr.. The value appears strong and on an upward trend. It has increased from 843.00 Cr. (Mar 2025) to 941.00 Cr., marking an increase of 98.00 Cr..
• For Total Assets, as of Sep 2025, the value is 2,081.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,954.00 Cr. (Mar 2025) to 2,081.00 Cr., marking an increase of 127.00 Cr..

Notably, the Reserves (897.00 Cr.) exceed the Borrowings (776.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Pitti Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 33.32. This value is within the healthy range. It has increased from 28.14 (Mar 24) to 33.32, marking an increase of 5.18.
• For Diluted EPS (Rs.), as of Mar 25, the value is 33.32. This value is within the healthy range. It has increased from 28.14 (Mar 24) to 33.32, marking an increase of 5.18.
• For Cash EPS (Rs.), as of Mar 25, the value is 53.85. This value is within the healthy range. It has increased from 44.98 (Mar 24) to 53.85, marking an increase of 8.87.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 238.61. It has increased from 129.83 (Mar 24) to 238.61, marking an increase of 108.78.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 238.61. It has increased from 129.83 (Mar 24) to 238.61, marking an increase of 108.78.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 452.60. It has increased from 374.81 (Mar 24) to 452.60, marking an increase of 77.79.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 82.29. This value is within the healthy range. It has increased from 70.47 (Mar 24) to 82.29, marking an increase of 11.82.
• For PBIT / Share (Rs.), as of Mar 25, the value is 60.91. This value is within the healthy range. It has increased from 53.62 (Mar 24) to 60.91, marking an increase of 7.29.
• For PBT / Share (Rs.), as of Mar 25, the value is 42.91. This value is within the healthy range. It has increased from 38.03 (Mar 24) to 42.91, marking an increase of 4.88.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 32.47. This value is within the healthy range. It has increased from 28.13 (Mar 24) to 32.47, marking an increase of 4.34.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 32.47. This value is within the healthy range. It has increased from 28.13 (Mar 24) to 32.47, marking an increase of 4.34.
• For PBDIT Margin (%), as of Mar 25, the value is 18.18. This value is within the healthy range. It has decreased from 18.80 (Mar 24) to 18.18, marking a decrease of 0.62.
• For PBIT Margin (%), as of Mar 25, the value is 13.45. This value is within the healthy range. It has decreased from 14.30 (Mar 24) to 13.45, marking a decrease of 0.85.
• For PBT Margin (%), as of Mar 25, the value is 9.48. This value is below the healthy minimum of 10. It has decreased from 10.14 (Mar 24) to 9.48, marking a decrease of 0.66.
• For Net Profit Margin (%), as of Mar 25, the value is 7.17. This value is within the healthy range. It has decreased from 7.50 (Mar 24) to 7.17, marking a decrease of 0.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.17. This value is below the healthy minimum of 8. It has decreased from 7.50 (Mar 24) to 7.17, marking a decrease of 0.33.
• For Return on Networth / Equity (%), as of Mar 25, the value is 13.60. This value is below the healthy minimum of 15. It has decreased from 21.66 (Mar 24) to 13.60, marking a decrease of 8.06.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.56. This value is within the healthy range. It has decreased from 22.53 (Mar 24) to 17.56, marking a decrease of 4.97.
• For Return On Assets (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has decreased from 6.78 (Mar 24) to 6.10, marking a decrease of 0.68.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.63 (Mar 24) to 0.31, marking a decrease of 0.32.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.64. This value is within the healthy range. It has decreased from 1.29 (Mar 24) to 0.64, marking a decrease of 0.65.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has decreased from 1.04 (Mar 24) to 1.02, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.25 (Mar 24) to 1.22, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.75, marking a decrease of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.69. This value is within the healthy range. It has increased from 3.14 (Mar 24) to 5.69, marking an increase of 2.55.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 4.35. This value is below the healthy minimum of 20. It has increased from 4.26 (Mar 24) to 4.35, marking an increase of 0.09.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.62. This value is below the healthy minimum of 20. It has decreased from 2.66 (Mar 24) to 2.62, marking a decrease of 0.04.
• For Earning Retention Ratio (%), as of Mar 25, the value is 95.65. This value exceeds the healthy maximum of 70. It has decreased from 95.74 (Mar 24) to 95.65, marking a decrease of 0.09.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.38. This value exceeds the healthy maximum of 70. It has increased from 97.34 (Mar 24) to 97.38, marking an increase of 0.04.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 4.57. This value is within the healthy range. It has increased from 4.52 (Mar 24) to 4.57, marking an increase of 0.05.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.80. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 24) which recorded 2.80.
• For Enterprise Value (Cr.), as of Mar 25, the value is 4,375.37. It has increased from 2,875.86 (Mar 24) to 4,375.37, marking an increase of 1,499.51.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.57. This value is within the healthy range. It has increased from 2.39 (Mar 24) to 2.57, marking an increase of 0.18.
• For EV / EBITDA (X), as of Mar 25, the value is 14.12. This value is within the healthy range. It has increased from 12.73 (Mar 24) to 14.12, marking an increase of 1.39.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 2.04 (Mar 24) to 2.31, marking an increase of 0.27.
• For Retention Ratios (%), as of Mar 25, the value is 95.64. This value exceeds the healthy maximum of 70. It has decreased from 95.73 (Mar 24) to 95.64, marking a decrease of 0.09.
• For Price / BV (X), as of Mar 25, the value is 4.38. This value exceeds the healthy maximum of 3. It has decreased from 5.88 (Mar 24) to 4.38, marking a decrease of 1.50.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.31. This value is within the healthy range. It has increased from 2.04 (Mar 24) to 2.31, marking an increase of 0.27.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness